We are live on
!
Find out more
Viking Global Investors Portfolio holdings
AUM
$35.7B
1-Year Est. Return
21.3%
This Fund
S&P 500
This Quarter
Est. Return
+6.29%
1 Year Est. Return
+21.3%
3 Year Est. Return
+91.13%
5 Year Est. Return
+89.39%
10 Year Est. Return
+464.55%
AUM
$22.3B
AUM Growth
+$4.85B
(+28%)
Cap. Flow
+$4.03B
Cap. Flow
% of AUM
18.06%
Top 10 Holdings %
Top 10 Hldgs %
53.96%
Holding
76
New
19
Increased
16
Reduced
22
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adaptive Biotechnologies
ADPT
|
+$1.7B |
| 2 |
Boeing
BA
|
+$1.01B |
| 3 |
Amazon
AMZN
|
+$915M |
| 4 |
Meta Platforms (Facebook)
META
|
+$902M |
| 5 |
BridgeBio Pharma
BBIO
|
+$726M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$889M |
| 2 |
Marathon Petroleum
MPC
|
+$823M |
| 3 |
Visa
V
|
+$440M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$314M |
| 5 |
BERY
Berry Global Group, Inc.
BERY
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.43% |
| 2 | Technology | 16.88% |
| 3 | Consumer Discretionary | 15.43% |
| 4 | Communication Services | 13.36% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Adaptive Biotechnologies
ADPT
$3.6B
| $1.86B | 8.32% |
+38,406,607
| New | +$1.7B |
|
|
2
Amazon
AMZN
$2.48T
| $1.52B | 6.82% |
16,056,740
+9,822,360
| +158% | +$915M |
|
3
Elevance Health
ELV
$83.7B
| $1.47B | 6.58% |
5,198,006
-996,880
| -16% | -$272M |
|
|
4
Meta Platforms (Facebook)
META
$1.51T
| $1.36B | 6.12% |
7,063,705
+4,934,406
| +232% | +$902M |
|
5
UnitedHealth
UNH
$389B
| $1.17B | 5.27% |
4,812,185
+1,071,149
| +29% | +$258M |
|
6
Microsoft
MSFT
$2.92T
| $1.03B | 4.63% |
7,704,063
-2,069,837
| -21% | -$263M |
|
|
7
Boeing
BA
$175B
| $1.01B | 4.54% |
+2,777,120
| New | +$1.01B |
|
8
JD.com
JD
$42.9B
| $964M | 4.33% |
31,821,898
+20,269,351
| +175% | +$583M |
|
9
RTX Corp
RTX
$295B
| $878M | 3.94% |
10,716,062
-545,438
| -5% | -$45.6M |
|
10
Netflix
NFLX
$301B
| $760M | 3.41% |
20,676,980
+683,220
| +3% | +$24.6M |
|
11
Centene
CNC
$31.6B
| $734M | 3.29% |
13,994,550
+9,795,824
| +233% | +$529M |
|
|
12
BridgeBio Pharma
BBIO
$16.8B
| $718M | 3.22% |
+26,620,991
| New | +$726M |
|
13
Uber
UBER
$144B
| $620M | 2.78% |
+13,368,682
| New | +$567M |
|
14
Monster Beverage
MNST
$95.6B
| $565M | 2.54% |
+17,703,894
| New | +$533M |
|
15
Mercado Libre
MELI
$94.4B
| $523M | 2.35% |
854,831
+242,962
| +40% | +$135M |
|
16
Illumina
ILMN
$29.2B
| $505M | 2.27% |
1,409,477
+194,048
| +16% | +$61.3M |
|
17
Salesforce
CRM
$149B
| $443M | 1.99% |
+2,922,394
| New | +$458M |
|
18
Liberty Media Series C
FWONK
$25.4B
| $426M | 1.91% |
11,769,612
-300,661
| -2% | -$10.9M |
|
19
Boston Scientific
BSX
$68.5B
| $395M | 1.77% |
9,195,192
+5,974,823
| +186% | +$230M |
|
|
ATVI
20
DELISTED
Activision Blizzard
ATVI
| $373M | 1.68% |
7,908,859
+2,999,492
| +61% | +$138M |
|
21
Adobe
ADBE
$99B
| $358M | 1.61% |
1,214,269
-827,919
| -41% | -$230M |
|
22
Align Technology
ALGN
$12.6B
| $318M | 1.43% |
1,161,145
-634,845
| -35% | -$192M |
|
23
Alphabet (Google) Class A
GOOGL
$4.08T
| $306M | 1.37% |
5,642,920
-1,849,620
| -25% | -$107M |
|
|
EXAS
24
DELISTED
Exact Sciences
EXAS
| $267M | 1.2% |
2,264,674
-950,308
| -30% | -$95.8M |
|
25
Micron Technology
MU
$927B
| $248M | 1.11% |
6,431,167
+4,141,275
| +181% | +$158M |
|
Similar funds
SAM
Viking Global Investors's Q2 2019 Portfolio in Review
As of Q2 2019, Viking Global Investors held 76 positions worth $22.3B, up 28% from $17.4B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Viking Global Investors deployed $4.03B of net new capital in Q2 2019, opening 19 new positions and adding to 16 existing holdings. Its largest new stake was Adaptive Biotechnologies: 38,406,607 shares worth $1.86B.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Alibaba, an estimated $889M trimmed.
- Viking Global Investors's largest Q2 2019 buy was Adaptive Biotechnologies: 38,406,607 shares worth $1.86B.
- Viking Global Investors added most to Amazon in Q2 2019, an estimated $915M increase.
- Viking Global Investors's biggest Q2 2019 reduction was Alibaba, cutting an estimated $889M.
- Viking Global Investors fully exited Marathon Petroleum in Q2 2019, selling an estimated $823M.
- Viking Global Investors's ten largest holdings make up 54% of its $22.3B portfolio in Q2 2019.
- Viking Global Investors opened 19 new positions and closed 17 in Q2 2019.
- Viking Global Investors's portfolio value rose 28% quarter-over-quarter to $22.3B.
Based on Viking Global Investors's 13F filing for Q2 2019, filed 14 Aug 2019.